TD ASSET MANAGEMENT INC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 157 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2021$629,000
+13.7%
63,827
+25.1%
0.00%0.0%
Q4 2020$553,000
+23.4%
51,001
+17.2%
0.00%0.0%
Q3 2020$448,000
-70.8%
43,501
-40.8%
0.00%
-50.0%
Q2 2020$1,535,000
+116.5%
73,501
+1.3%
0.00%
+100.0%
Q1 2020$709,000
+8.9%
72,538
+28.3%
0.00%0.0%
Q4 2019$651,000
+98.5%
56,550
-6.1%
0.00%0.0%
Q3 2019$328,000
+88.5%
60,250
+312.7%
0.00%
Q2 2019$174,00014,6000.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2020
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders